• 1
    Lum ME, McMillan AJ, Brook CW, Lester R, Piers LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust. 2009;191:5026.
  • 2
    Kelly HA, Grant KA, Williams S, et al. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust. 2009;191(3):1469.
  • 3
    Al-Khayat R, Jennings R, Potter CW. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial hemolysis. Journal of Hygiene. 1984(92):30112.
  • 4
    Newall AT, Kelly H, Harley S, Saffham PA. Cost effectiveness of Influenza vaccination in Older Adults; A Critical Review of Economic Evaluationf for the 50 t0 64 year age group. Pharmacoeconomics. 2009;27(6):43950.
  • 5
    Newall AT, Saffham PA, Kelly H, Harsley H, MacIntyre CR. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine. 2008;26(17):214253.
  • 6
    Family Medicine Research Centre. BEACH (Bettering the Evaluation and Care of Health) Report – Influenza Among Patients Aged 50-64 Years in General Practice 2000-2006. Sydney ( AUST ) : The University of Sydney at Westmead Hospital; 2007.
  • 7
    Fleming DM, Zambon M, Bartelds AIM, DJong JC. The duration and magnitude of nfluenza epidemics: A Study of surveillance data from sentinel general practices in England, Wales and the Naetherlands. Eur J Epidemiol. 1999;15(5):46773.
  • 8
    Fielding JE, Higgins N, Gregory JE, Grant KA, Catton MG, Bergen I, et al. Pandemic H1N1 Surveillance in Victoria, Australia, April-September 2009. Euro Surveill. 2009;14(42):pii=19368.
  • 9
    United States Government Department of Health and Human Services. Atlanta (GA): Centers for Disease Control and Prevention; 2009 [cited 2009 Sep). Pandemic Influenza Resources. Pandemic Influenza Preparedness Book for Professionals. Available from:
  • 10
    Department of Health and Ageing. Pandemic Influenza. Australian Health Management Plan for Pandemic Influenza. Canberra ( AUST ) : Commonwealth of Australia; 2008.
  • 11
    Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 Pandemic H1N1 influenza virus. N Engl J Med. 2009;361:194552.
  • 12
    Chen H, Wang Y, Liu W, et al. Serologic survey of Pandemic (H1N1) 2009 virus, Guangsu Province, China. Emerg Infect Dis. 2009;15(11):184950.
  • 13
    Greenberg ME, Lai M, Hartel GF, et al. Response after one dose of a Monovalent nfluenza A (H1N1) 2009 vaccine – preliminary report. N Engl J Med. 2009;361(25):240513.
  • 14
    Carrat F, Vergu E, Ferguson NM, et al. Timelines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:77585.